DTL
AGRX

Dynamic Technology Lab’s Agile Therapeutics AGRX Stock Holding History

Dynamic Technology Lab’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10
Closed -$64K – 1404
2017
Q1 		$64K Buy
+10
New +$50.3K 0.02% 912

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dynamic Technology Lab's AGRX Position: Q2 2017 in Review

Dynamic Technology Lab sold out of Agile Therapeutics (AGRX) in Q2 2017, closing a stake of 10 shares — an estimated $64K sold.

Dynamic Technology Lab first reported a position in AGRX in Q1 2017 and held it in 1 quarter. The position peaked at $64K in Q1 2017. 41 funds tracked by Wall St. Rank hold AGRX as of Q2 2017.

  • Dynamic Technology Lab reported no remaining Agile Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Dynamic Technology Lab sold 10 Agile Therapeutics shares in Q2 2017, an estimated $64K.
  • Dynamic Technology Lab first reported a position in Agile Therapeutics in Q1 2017 and held it in 1 quarter.
  • Dynamic Technology Lab's Agile Therapeutics position peaked at $64K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2017.

Based on Dynamic Technology Lab's 13F filing for Q2 2017, filed 17 Aug 2017.